The language that was allowed in Mississippi was “To the extent authorized to do so under the laws of the State of Mississippi.” During negotiations, it was divulged that the State does not authorize anyone
to accept indemnification; thus, the agency/sponsor knew that the clause was null. What was the purpose? This allowed the clause to remain in the agreement which was required by the agency/sponsor while allowing the University to sign the agreement. This
might be something that you run past your legal. Good luck!
Leronda Savage
Sr. Clinical Project Accountant
Clinical Trials Finance Office
262 Danny Thomas Place, MS-720
Memphis, TN 38105-3678
Office:
901-595-0302
Cell: 662-801-6115
Fax: 901-525-9015
Email Disclaimer:
www.stjude.org/emaildisclaimer
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Jennifer Shambrook
Sent: Monday, September 26, 2016 4:53 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Indemnification question
Florida is in the same situation. Due to an “incident” we can no longer accept “to the extent allowed by applicable law” either. At one time, we could. We now cannot assume indemnity, period. Therefore, we go
through the UCF Research Foundation as our work-around.
Jennifer
Jennifer Shambrook, Ph.D.
Director of Research Programs and Services
Office of Research & Commercialization
University of Central Florida
12201 Research Parkway, Suite 501
Orlando, FL 32826-3246
Phone: (407)823-0387
Fax: (407)823-3299
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Smith, Debbie L
Sent: Monday, September 26, 2016 3:55 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Indemnification question
Following an “incident” in our state, our attorney general has issued an order to state institutions prohibiting us from signing ANY indemnification or hold harmless clauses, even if modified by “to the extent allowed by applicable law.”
Needless to say, it has made negotiations much more difficult for us.
Debbie
Deborah L. Smith, Ed.D.
Associate Vice Chancellor for Research
UTHSC
910 Madison, Suite 823
Memphis, TN 38163
901 448-4823 – office
901 448-7600 – fax
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of dougm (Doug Mounce)
Sent: Monday, September 26, 2016 12:30 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Indemnification question
Excuse me for interrupting, but did the feds simply want general indemnification in this case? I’m asking because we’ve been considering the particular language of the Accelerated Clinical Trial Agreement (ACTA),
and the risk of subject injury on a clinical trial is one reason for being careful with indemnification. The FDP subcontract work group is supposedly working on a template for clinical trials.
The current template for, “Subaward Agreements for Use Under Federally Sponsored Clinical Trials” only states:
[… Additional terms and conditions should be strictly limited to those absolutely required. Please do not include indemnification,
law and venue clauses, as public institutions can never accept these conditions.]
If the ACTA is adopted, then would the indemnification below generally be acceptable for an institution with particular state limitations?
Subject
to the limits
and
without
waiving
any
immunities
provided
under
applicable law (including
constitutional
provisions,
statutes
and
case law) regarding
the status,
powers
and authority
of the Institution
or the Institution’s
principal(s),
Institution
shall indemnify,
hold
harmless
and
defend
Sponsor,
its
directors,
officers,
employees and
agents,
(“Sponsor’s
Indemnitees”)
from
and
against only those third
party Claims to the
extent
directly
attributable to
Institution’s negligence
in its conduct of the
Study.
Notwithstanding
the above,
Institution
shall have
no obligation
to
indemnify Sponsor
for
any other
Claims
(including,
but not limited
to, infringement
or product
liability
Claims).
thanks! Doug Mounce, Grants & Contracts Manager, 206-839-1787
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Carolyn Elliott-Farino
Sent: Monday, September 26, 2016 7:47 AM
To: xxxxxx@lists.healthresearch.org
Subject: [SUSPICIOUS URL!]Re: [RESADM-L] Indemnification question
Thank you, Jennifer, for clarifying my statement so eloquently. When I said that indemnification, etc., does not bind the RF, that was a bit of a misnomer. Such clauses do, of course, bind the RF, but the RF
is able to accept such restrictions. We have insurance and we evaluate the actual risk involved in the project. Nearly every agreement we accept/sign, save federal grants, has an indemnification clause of some sort, even when the project involves little or
no risk. People are very risk averse.
Carolyn Elliott-Farino
Executive Director, Office of Research
Kennesaw State University &
Kennesaw State University Research and Service Foundation
3413 Kennesaw Hall, MD #0111
585 Cobb Avenue, Kennesaw, GA 30144
470-578-6381
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Sharp, William C.
Sent: Monday, September 26, 2016 8:36 AM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Indemnification question
Hi, Jennifer,
Thanks so much for that frank clarification--that was really eye opening!
Bill
William Sharp, Ph.D.
Assistant Director, Research Administration
Office of Research | The University of Kansas
2385 Irving Hill Road
Lawrence, KS 66045
(785) 864-7430 | xxxxxx@ku.edu
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Jennifer Shambrook
Sent: Monday, September 26, 2016 6:30 AM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Indemnification question
Hi Bill and Carolyn, et al.,
We have the same issue here at UCF, we cannot accept indemnification language here at UCF under the state university banner, but can under our DSO, the UCF Research Foundation. We are in the same state university
system as FSU.
While you are correct,Bill, we are just shifting the risk from one entity to the other, we are shifting from an entity that cannot accept the language to an entity that can. While indemnifying is not ideal, it
is not a deal breaker for the RF and it is for the university.
Is it a possibility that the RF (or the Uni for that matter) could end up getting sued for large sums of money with the indemnification language in place? yes; is it a probability? Not likely.
It would be a shame to turn down an award and prohibit the work for proceeding just in the unlikely chance that we might be sued.
-Jennifer
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Sharp, William C.
Sent: Saturday, September 24, 2016 10:59 AM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Indemnification question
Carolyn,
You make an interesting point that I am not entirely following. Can you clarify how accepting indemnification, state law, etc. contract terms under the guise of the research foundation would not be binding for
the research foundation? Isn’t it just moving the problematic clauses from one entity to another? Or is that the point? (Sorry I am not getting your point on the first swing of the bat, but I’m struggling like the Royals at this point in the season…)
Bill
William Sharp, Ph.D.
Assistant Director, Research Administration
Office of Research | The University of Kansas
2385 Irving Hill Road
Lawrence, KS 66045
(785) 864-7430 | xxxxxx@ku.edu
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Carolyn Elliott-Farino
Sent: Friday, September 23, 2016 3:50 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Indemnification question
Russell,
Why wouldn’t this be a reason to accept the award through your research foundation? As I recall, FSU’s research foundation accepts only non-federal awards and prefers to accept federal awards through the university.
One of the reasons state universities establish research foundations is because of issues such as indemnification, state law, and insurance limits, none of which bind the research foundation. That would be a reason for your institution to make an exception.
Not accepting the award when you have a mechanism through which you can do it makes no sense to me.
Carolyn Elliott-Farino
Executive Director, Office of Research
Kennesaw State University &
Kennesaw State University Research and Service Foundation
3413 Kennesaw Hall, MD #0111
585 Cobb Avenue, Kennesaw, GA 30144
470-578-6381
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org]
On Behalf Of Lentz, Russell
Sent: Friday, September 23, 2016 12:04 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] Indemnification question
Has anybody had a federal agency refuse to limit indemnification to your state’s statutory sovereign immunity limits? If so, how did you handle it? Did you have to choose not to accept the award, to find someone
else at the agency, or some other alternative? We have received but not yet accepted two awards that include a FAR clause requiring FSU to indemnify without limits. The federal agency is refusing to limit indemnification despite our sending of both the Florida
statute and Attorney General Legal Opinion that limit indemnification to $300,000. Any guidance would be appreciated!
Thanks,
Russ
Russell D. Lentz
Associate Director
Sponsored Research Administration (Pre-Award)
Florida State University
874 Traditions Way
Tallahassee, FL 32306-4166
(850) 644-8649
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at http://www.healthresearch.org
(click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at http://www.healthresearch.org
(click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at http://www.healthresearch.org
(click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at http://www.healthresearch.org
(click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at http://www.healthresearch.org
(click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at http://www.healthresearch.org
(click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br>
======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at
http://www.healthresearch.org (click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br> ======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at
http://www.healthresearch.org (click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br> ======================================================================<br>
Email secured by Check Point
<br> ======================================================================<br> Instructions on how to use the RESADM-L Mailing List, including<br> subscription information
and a web-searchable archive, are available<br> via our web site at
http://www.healthresearch.org (click on the<br> "LISTSERV" link in the upper right corner)<br> <br> A link directly to helpful tips:
http://tinyurl.com/resadm-l-help<br> ======================================================================<br>